Structured evidence table for Magnesium Sleep Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Magnesium Sleep Randomized Trial | It points towards the lack of any analgesic effect of zoledronate, and above all to a latent vulnerability of osteoporotic women who are at a potential risk of fracture with a poor pain modulation that needs to be researched further to limit future chronification. | 2 | Pickering ME (2026) | Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation. |
| Magnesium Sleep Randomized Trial | Background Bisphosphonates (BP) are a recommended treatment for osteoporosis and an analgesic effect has been suggested. | 2 | Pickering ME (2026) | Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation. |
| Magnesium Sleep Randomized Trial | Magnesium is involved in pain mechanisms, mood disorders and also in bone homeostasis. | 2 | Pickering ME (2026) | Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation. |
| Magnesium Sleep Randomized Trial | Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Magnesium Sleep Randomized Trial | While both the quantity and the quality of sleep can be largely improved with relatively straightforward practices dictated by good sleep hygiene, emerging research suggests that dietary and supplementation protocols focused on certain foods, nutrients, and biochemical compounds with sleep-promoting properties can act as subsidiary sleep aids in complementing these behavioral changes. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Magnesium Sleep Randomized Trial | The scope of this narrative review is to summarize the available evidence on the potential benefits of selected nutraceuticals in the context of circadian rhythm and sleep disturbances, namely melatonin, magnesium, omega-3 fatty acids, tart cherry juice, kiwifruit, apigenin, valerian root, L-theanine, glycine, ashwagandha, myoinositol, Rhodiola rosea, and phosphatidylserine. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Magnesium Sleep Randomized Trial | Humans spend approximately one third of their life asleep but, as counterintuitive as it may sound, sleep is far from being a quiet state of inactivity. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
Source documents